Revolutionizing Cancer Treatment: The Promise of Yttrium-90 Microspheres in Radioembolization Therapy February 15, 2024
Next Steps for Yttrium-90 Microspheres Registration in South Korea and China for Liver Cancer Treatment February 12, 2024
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifescience December 12, 2023
Rafarma Pharmaceuticals Signed a Preliminary Agreement for Radiopharmaceutical Production Center November 30, 2023
